| 6.1 - 11.1 | 3.9 - 11.1 | P | logistics |
n | 415 | 510 |
|
|
Age, median [Q1, Q3] | 55.00 [44.00, 65.00] | 54.00 [43.00, 65.00] | <0.001* | 0.407 |
Male, n | 249 | 307 | 1.000 | / |
Male, (%) | 60.00% | 60.20% | ||
ethnicity |
|
|
|
|
white, n | 256 | 312 |
|
|
white, (%) | 61.69% | 61.18% |
|
|
BLACK/AFRICAN AMERICAN, n | 51 | 59 |
|
|
BLACK/AFRICAN AMERICAN, (%) | 12.29% | 11.57% |
|
|
AMERICAN INDIAN/ALASKA NATIVE, n | 2 | 2 |
|
|
AMERICAN INDIAN/ALASKA NATIVE, (%) | 0.48% | 0.39% |
|
|
PORTUGUESE, n | 4 | 4 |
|
|
PORTUGUESE, (%) | 0.96% | 0.78% |
|
|
UNKNOWN, n | 50 | 63 |
|
|
UNKNOWN, (%) | 12.05% | 12.35% |
|
|
ASIAN, n | 12 | 14 |
|
|
ASIAN, (%) | 2.89% | 2.75% |
|
|
OTHER, n | 16 | 21 |
|
|
OTHER, (%) | 3.86% | 4.12% |
|
|
HISPANIC/LATINO, n | 13 | 21 |
|
|
HISPANIC/LATINO, (%) | 3.13% | 4.12% |
|
|
UNABLE TO OBTAIN, n | 11 | 14 |
|
|
UNABLE TO OBTAIN, (%) | 2.65% | 2.75% |
|
|
Aps III, median [Q1, Q3] | 62.00 [43.00, 87.50] | 59.00 [41.00, 84.00] | 0.134 | / |
inSOFA, median [Q1, Q3] | 1.00 [0, 4.00] | 1.00 [0, 4.00] | 0.986 | / |
▲SOFA, median [Q1, Q3] | 1.00 [−1.00, 3.00] | 1.00 [−1.00, 3.00] | 0.992 | / |
Glu_meana (mmol/L), median [Q1, Q3] | 7.88 [7.00, 8.92] | 7.55 [6.42, 8.61] | <0.001* | / |
Glu_cvb, median [Q1, Q3] | 0.23 [0.17, 0.33] | 0.22 [0.16, 0.31] | 0.126 | / |
Glu_frequency* (n/day), median [Q1, Q3] | 4.59 [3.63, 6.34] | 4.43 [3.24, 6.10] | 0.088 | 0.243 |
LOS in ICUc, median [Q1, Q3] | 5.83 [3.14, 13.74] | 4.95 [2.96, 11.67] | 0.072 | / |
LOS in hospitald, median [Q1, Q3] | 17.76 [9.99, 28.95] | 16.62 [9.03, 26.71] | 0.091 | / |
antibiotic day, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [0, 3.00] | 0.610 | / |
die, n | 204 | 241 | 0.597 | / |
die, (%) | 49.16% | 47.25% | ||
blood-infection, n | 123 | 142 | 0.004 | / |
blood-infection, (%) | 29.64% | 27.84% | ||
Abdominal-infection, n | 60 | 71 | 0.850 | / |
Abdominal-infection, (%) | 14.46% | 13.92% | ||
urinary-infection, n | 45 | 57 | 0.916 | / |
urinary-infection, (%) | 10.84% | 11.18% | ||
respiratory-infection, n | 71 | 78 | 0.473 | / |
respiratory-infection, (%) | 17.11% | 15.29% | ||
diabetes, n | 135 | 148 | 0.252 | / |
diabetes, (%) | 32.53% | 29.02% | ||
hypoglycemia, n | 7 | 11 | 0.642 | / |
hypoglycemia, (%) | 2.81% | 3.58% | ||
die, n | 62 | 68 | 0.5063 | / |
die, (%) | 14.94% | 13.33% | ||
hyperlipidemia, n | 85 | 96 | 0.56 | / |
hyperlipidemia, (%) | 34.14% | 31.27% |